Tag: pancreatic cancer

Featured Health & Pharmaceuticals

Actavis launches Gemcitabine on patent expiry in EU markets

March 13, 20092 min read

The international generic pharmaceuticals company, Actavis Group, has launched the oncology product Gemcitabine in EU markets, at patent expiry. This launch represents a significant milestone

Actavis, bladder cancer, breast cancer, EU, Gemcitabine, hospital business, lung cancer, oncology treatment, pancreatic cancer, patent expiry, treatment of cancer

You May Have Missed

Business Retail & Services Software

Inzynk takes focus on the UK to Dismantle B2B MarTech’s Per-Seat ‘SaaS Tax’

October 6, 2026October 6, 2026

Health & Pharmaceuticals

Xpress Health NI Expands Nursing Opportunities Across Northern Ireland to Meet Surging Healthcare Demand

October 6, 2026

Business

Growing Manufacturing Workforce Requirements Create Opportunities for International Workers

October 6, 2026

Business IT & Technology

Site Design Squad Launches Hands-On Web Accessibility Audits for Small Businesses and Charities

October 4, 2026October 6, 2026